IMPACT
99 years and younger
All genders
This is a multicenter, prospective, single-arm trial to demonstrate the safety and effectiveness of the use of Impella 5.5 in high-risk cardiac surgery patients, with the aim to evaluate if it perioperatively improves early hemodynamics, end-organ function and clinical outcomes in patients with severely reduced LV function undergoing cardiac surgery. …